References
- Australian Institute of Health & Welfare. 2001 National Drug Strategy Household Survey: First Results. AIHW cat no. PHE 35. (Drug Statistics Series No. 9). Canberra, Australian Institute of Health & Welfare (2002).
- Ridolfo B, Stevenson C. Quantification of Drug-Caused Mortality and Morbidity in Australia, 1998. Canberra: Australian Institute of Health and Welfare (2001).
- Collins D, Lapsley H. Counting the costs: estimates of the social costs of drug abuse in Australia in 1998–9. Canberra: Commonwealth Department of Health and Ageing (2002).
- Australian Government Department of Health and Ageing. Schedule of pharmaceutical benefits for approved pharmacists and medical practitioners. Canberra: Commonwealth of Australia (2001).
- Australian Government Department of Health and Ageing. Schedule of pharmaceutical benefits for approved pharmacists and medical practitioners. Canberra: Commonwealth of Australia (2004).
- Doran CM, Shakeshaft AP, Gates JA, Fawcett JE, Mattick RP. Current prescribing patterns of bupropion in Australia. Med. J. Aust.177, 162 (2003).
- National Drug and Alcohol Research Centre. Illicit Drug Reporting System. Canberra: Department of Health and Ageing (2002).
- Medical Outcomes Trust. SF-36 Health Survey. Boston (1994).
- Rintoul D, Borland R, Young S. Barriers to Access of Smoking Cessation Programs, Nicotine Replacement Therapy and other Pharmacotherapies. Urbis Keys Young, Melbourne (2002).
- Australian Bureau of Statistics. 2001 Census of Population and Housing: First Release Data. Canberra. Australian Bureau of Statistics (2002).
- SPSS. SPSS for windows (Statistical Program for the Social Sciences). SPSS Inc, Chicago (2000).